SL PHARM(SZ:002038) Xin Lang Cai Jing·2025-11-21 03:09Group 1 - The core viewpoint of the news is that Shuanglu Pharmaceutical's stock has been declining for four consecutive days, with a total drop of 4.96% during this period, leading to a current stock price of 7.28 CNY per share and a market capitalization of 7.479 billion CNY [1] - Shuanglu Pharmaceutical, established on December 24, 1994, and listed on September 9, 2004, focuses on the research, development, and production of gene-engineered and related drugs, with its main business revenue composition being 56.82% from chemical drugs, 39.41% from biological and biochemical drugs, and 2.52% from other sources [1] - The trading volume for Shuanglu Pharmaceutical reached 98.4236 million CNY, with a turnover rate of 1.55% [1] Group 2 - Among the top ten circulating shareholders of Shuanglu Pharmaceutical, Huaxia Fund's Huaxia CSI 1000 ETF (159845) has recently entered the list, holding 3.9085 million shares, which accounts for 0.46% of the circulating shares [2] - The Huaxia CSI 1000 ETF has experienced a floating loss of approximately 152.43 thousand CNY today and a total floating loss of 156.34 thousand CNY during the four-day decline [2] - The Huaxia CSI 1000 ETF was established on March 18, 2021, with a current scale of 45.469 billion CNY, and has achieved a year-to-date return of 24.61% [2]